Dovato (dolutegravir/lamivudine)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dovato (dolutegravir/lamivudine), covering 2025-06-26 to 2025-06-26. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability and Effectiveness of DTG/3TC vs BIC/TAF/FTC in PWH Without Antiretroviral Experience [Phase 4]